Trials / Completed
CompletedNCT01655160
Effects and Mechanisms of Treatment Intensity of Mirror Therapy in Patients With Subacute Stroke
Effects and Mechanisms of Treatment Intensity of Mirror Therapy in Patients With Subacute Stroke: Outcomes in Brain and Movement Reorganization, Sensorimotor and Daily Functions, and Measures of Physiological Markers.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Chang Gung Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study will evaluate the long-term benefits, optimal dose and mechanisms of mirror therapy and its effects on physiological markers.
Detailed description
This trial is to examine whether (1) the immediate effects of treatment intensity in MT would occur on sensorimotor impairments and functional performance in patients with subacute stroke; (2) the long-term benefits of treatment intensity in MT on functionality can persist for six months after treatment finished; and (3) the MT could result in cortical/movement reorganization as well as the changes in physiological markers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | MT with low-intensity group (MT-LI) | The MT-LI group will receive a 30-minute MT per session followed by a 30-minute functional training. |
| BEHAVIORAL | MT with moderate-intensity group | The MT-MI group will receive a 60-minute MT per session followed by a 30-minute functional training. |
| BEHAVIORAL | Mirror therapy with high intensity group | The MT-HI group will receive a 90-minute MT per session followed by a 30-minute functional training |
| BEHAVIORAL | Control intervention group | The CI group will carry out a 30-minute conventional stroke rehabilitation training per session followed by a 30-minute functional training. |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2012-08-01
- Last updated
- 2015-06-08
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01655160. Inclusion in this directory is not an endorsement.